Pipeline

V-Smart®Designed for
Medical Indication
Engineered to TargetCustomized with Therapeutic Agent 1Grantor/PartnerPre-Clinical 4Phase 1
LAUR-101PDDopaminergic NeuronsGDNF 2
(Protein)
LAUR-201HIVAll CNSTenofovir 3
(Small Molecule)
LAUR-301ALS
(Orphan Disease)
Deteriorating Motor NeuronsGDNF 2
(Protein)
LAUR-401GBM
(Orphan Disease)
Tumor Specific AntigenChemotherapeutic 3
(Small Molecule)
LAUR-501NPC
(Orphan Disease)
All CNSCyclodextrin 2
(Small Molecule)
LAUR-601ADDeteriorating Brain Neurons in AD Neurotrophin 2
(Protein)
INTERNAL
OTHERSRare/Orphan Disease, LSD, Neurodegenerative, Neuropsychiatric, Pain, Addiction, Etc. All CNS, Specific Target in CNS or ElsewhereSmall Molecule, Protein, Antibody, Peptide, Enzyme (ERT), Nucleic Acid, Etc. CONFIDENTIAL
1 Does not cross BBB
2 Clinical trial efficacy
3 FDA approved drug
4 Mice by i.v. administration